Medical Communications

Biogen announced that Jean-Paul Kress has been appointed to the position of Executive Vice President and President, International, and Head …

Sandoz, a division of Swiss pharma giant Novartis, has revealed that two of its biosimilars – Rixathon (biosimilar rituximab) and …

According to the patient records that have been examined so far, at least 1,700 may have been put at risk …

The July/August edition of Pharmafocus is now available – click here to read online.

Pamela Yeh, Assistant Professor at the Department of Ecology and Evolutionary Biology, University of California, Los Angeles, discusses how drug …

The British Medical Association has revealed that a poll, conducted by British doctors, shows that levels of public dissatisfaction with …

The Association of the British Pharmaceutical Industry (ABPI) has announced that it has taken the unusual step of extending the …

Pfizer has been dealt a stinging blow by the FDA, after it received a second complete response letter from the …

Novartis has revealed that its drug Tafinlar (dabrafenib) has received approval from the FDA for use in combination with Mekinist …

For the first time in English history, new diagnoses of HIV have fallen across the country – the drop was …

Rare cancers are not so rare after all. According to the organisation Rare Cancer Europe more than 4.3 million people …

We’re officially into summer, and the weekend is here. This week saw a number of stories that piqued the attention …

President Trump spoke often of how pharmaceutical companies were ‘getting away with murder’, in regards to drug pricing, and now …

Thermo Fisher Scientific Inc., the world leader in serving science, today announced new technologies that are designed to allow analytical …

Pharmafocus caughtup with Lawrence Blatt, Janssen’s Global Therapeutic Area Head, Infectious Diseases and Vaccines, to discuss the progress being made in the …